Literature DB >> 8080844

CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase.

A August1, B Dupont.   

Abstract

T lymphocyte activation requires recognition of antigen by the antigen specific TCR as well as second co-stimulatory signals. This recognition event results in the activation of non-TCR linked protein tyrosine kinases (PTKs). The mechanism of co-stimulation of T cells is unknown except for the involvement of PTKs. The T cell surface molecule CD28 is effective in delivering co-stimulatory signals and prevents T cell anergy by inducing T cell proliferation in TCR stimulated T cells, primarily due to an increase in IL-2 production. The mechanism by which CD28 mediates this effect is currently unknown. Some conventional receptor molecules possess intrinsic tyrosine kinase and as a consequence of cross-linking or ligand binding, phosphorylate numerous tyrosines within their cytoplasmic tail, leading these tyrosines to become 'activated' and bind cytoplasmic effector molecules possessing Src homology 2 domains which specifically recognize phosphorylated tyrosines. One such cytoplasmic effector molecule is the phosphatidylinositol-3-phosphate kinase (PI3 kinase) which recognizes the motif phosphotyrosine-methione/valine-X-methionine (X being any amino acid) within the cytoplasmic tails of numerous receptor tyrosine kinases. As CD28 contains a copy of the PI3 kinase binding motif within its cytoplasmic tail, we investigated CD28 signaling and PI3 kinase activation. Here we demonstrate using the Jurkat cell line that CD28 becomes tyrosine phosphorylated following CD28 cross-linking and associates with PI3 kinase. Furthermore, a synthetic peptide representing the YM/VXM motif within the cytoplasmic tail of CD28 also interacts with PI3 kinase only when the tyrosine is phosphorylated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8080844     DOI: 10.1093/intimm/6.5.769

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  31 in total

Review 1.  Regulation of integrin function by T cell activation: points of convergence and divergence.

Authors:  T Zell; W J Kivens; S A Kellermann; Y Shimizu
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  TCR-independent CD28-mediated gene expression in peripheral blood lymphocytes from donors chronically infected with HIV-1.

Authors:  J G Wong; M D Smithgall; O K Haffar
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 3.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 4.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 5.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

6.  Identification and regulatory analysis of rainbow trout tapasin and tapasin-related genes.

Authors:  Eric D Landis; Yniv Palti; Jenefer Dekoning; Robert Drew; Ruth B Phillips; John D Hansen
Journal:  Immunogenetics       Date:  2006-01-27       Impact factor: 2.846

Review 7.  Involvement of CD80 in the generation of CD4+ cytotoxic T cells.

Authors:  D Mauri; W J Pichler
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase.

Authors:  Anjali J de Souza; Jean S Oak; Ryan Jordanhazy; Rosemarie H DeKruyff; David A Fruman; Lawrence P Kane
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells.

Authors:  K S Zier; B Gansbacher
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.